Atypical antipsychotic drug actions: unitary or multiple mechanisms for ‘atypicality’?
- 1 May 2003
- journal article
- Published by Elsevier in Clinical Neuroscience Research
- Vol. 3 (1-2) , 108-117
- https://doi.org/10.1016/s1566-2772(03)00021-5
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [
S ]GTPγS binding studyEuropean Journal of Pharmacology, 1998 - Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptorsPsychopharmacology, 1994
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988
- Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potencyAmerican Journal of Psychiatry, 1980
- Serotonergic component of neuroleptic receptorsNature, 1978
- Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brainNeuropharmacology, 1977
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976
- Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine NeuronsScience, 1975
- Anti-muscarinic properties of neuroleptics and drug-induced ParkinsonismNature, 1974
- A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERSProceedings of the National Academy of Sciences, 1954